AI Article Synopsis
- * Treatment involved an intravitreal injection of Ranibizumab which successfully reduced macular edema, and further injections along with laser therapies were planned.
- * The findings suggest that using intravitreal anti-VEGF therapy can improve conditions associated with macular edema in patients with central venous occlusion due to Wyburn-Mason-Syndrome.
Article Abstract
The diagnostic findings, therapy and course of disease are described for a case of central venous occlusion in Wyburn-Mason-Syndrome. The diagnosis was based on OCT, fluorescein angiography and cMRI. In addition, due to the macular edema an intravitreal injection with Ranibizumab was applied. The macular edema regressed and further Ranibizumab-injections as well as a panretinal laser-coagulation and possibly a cryocoagulation were planned. For a central venous occlusion with macular edema also in Wyburn-Mason-Syndrome an intravitreal anti-VEGF-inhibition leads to an improvement.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00347-019-0927-x | DOI Listing |
Publication Analysis
Top Keywords
venous occlusion
12
macular edema
12
central venous
8
[central venous
4
occlusion wyburn-mason
4
wyburn-mason syndrome]
4
syndrome] diagnostic
4
diagnostic findings
4
findings therapy
4
therapy course
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!